Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model

BACKGROUND: KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro. Because the in vivo anti-tumor effect of BP3B is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye-Youn, Kim, Jinhee, Ha Thi, Huyen Trang, Bang, Ok-Sun, Lee, Won-Suk, Hong, Suntaek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116142/
https://www.ncbi.nlm.nih.gov/pubmed/27863496
http://dx.doi.org/10.1186/s12906-016-1447-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116142/
https://www.ncbi.nlm.nih.gov/pubmed/27863496
http://dx.doi.org/10.1186/s12906-016-1447-8

Ejemplares similares